Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2025-12-25 @ 12:20 PM
NCT ID: NCT00653861
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00653861
Study Brief: Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Juvéderm Lidocaine Nasolabial Folds (NLFs) Nasolabial folds on one side of the face injected with the Juvederm formulation with lidocaine None None 0 72 21 72 View
Juvéderm Nasolabial Folds (NLFs) Nasolabial folds on the corresponding side of the face injected with Juvederm None None 0 72 20 72 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection side induration SYSTEMATIC_ASSESSMENT General disorders None View
Injection site nodule SYSTEMATIC_ASSESSMENT General disorders None View
Injection site discoloration SYSTEMATIC_ASSESSMENT General disorders None View
Application site bruising SYSTEMATIC_ASSESSMENT General disorders None View
Injection site edema SYSTEMATIC_ASSESSMENT General disorders None View
Injection site erythema SYSTEMATIC_ASSESSMENT General disorders None View